0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug/Vaccine Safety
 41-60 of 226 Articles
Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;311(21):2162. doi:10.1001/jama.2014.6400.

Original Investigation |  FREE
Eric M. Mortensen, MD, MSc; Ethan A. Halm, MD, MPH; Mary Jo Pugh, PhD; et al.
JAMA. 2014;311(21):2199-2208. doi:10.1001/jama.2014.4304.
Includes: Supplemental Content

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(21):2159-2160. doi:10.1001/jama.2014.5090.

From the JAMA Network | 
Cindy England Owen, MD
JAMA. 2014;311(20):2121-2122. doi:10.1001/jama.2014.2323.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(20):2057. doi:10.1001/jama.2014.5757.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(20):2057. doi:10.1001/jama.2014.5759.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;311(20):2123. doi:10.1001/jama.2014.5289.

Editorial | 
Natalia Jiménez-Truque, MSCI, PhD; Kathryn M. Edwards, MD
JAMA. 2014;311(17):1736-1737. doi:10.1001/jama.2014.3555.

Preliminary Communication |  FREE
Flor M. Munoz, MD; Nanette H. Bond, PAC; Maurizio Maccato, MD; et al.
JAMA. 2014;311(17):1760-1769. doi:10.1001/jama.2014.3633.
Includes: Supplemental Content

Capitol Health Call | 
Mike Mitka, MSJ
JAMA. 2014;311(14):1389. doi:10.1001/jama.2014.3716.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(14):1386-1388. doi:10.1001/jama.2014.1827.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(12):1192. doi:10.1001/jama.2014.2602.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(12):1191. doi:10.1001/jama.2014.3044.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;311(12):1246. doi:10.1001/jama.2014.339.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(11):1097-1098. doi:10.1001/jama.2014.1697.

JAMA Clinical Evidence Synopsis | 
Karsten M. H. Bruins Slot, MD, PhD; Eivind Berge, MD, PhD
JAMA. 2014;311(11):1150-1151. doi:10.1001/jama.2014.1403.

Global Health | 
M. J. Friedrich
JAMA. 2014;311(11):1101. doi:10.1001/jama.2014.2580.

Capitol Health Call | 
Mike Mitka, MSJ
JAMA. 2014;311(10):1005. doi:10.1001/jama.2014.1175.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;311(10):1006. doi:10.1001/jama.2014.1616.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;311(10):1007. doi:10.1001/jama.2014.1622.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Cardiology
Invited Commentary  | 
Inflammation and Arterial Injury in Individuals With Human Immunodeficiency Virus Infection
James H. Stein, MD; Priscilla Y. Hsue, MD
JAMA Oncology
Original Investigation  | 
Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression A Subgroup Analysis of a Randomized Clinical Trial
Saby George, MD; Robert J. Motzer, MD; Hans J. Hammers, MD, PhD; et al.
JAMA Internal Medicine
Editorial  | 
Promise and Peril for Generic Drugs
Joshua M. Sharfstein, MD; Jeremy Greene, MD, PhD
JAMA Internal Medicine
Research Letter  | 
Prevalence and Predictors of Generic Drug Skepticism Among Physicians Results of a National Survey
Aaron S. Kesselheim, MD, JD, MPH; Joshua J. Gagne, PharmD, ScD; Wesley Eddings, PhD; et al.